| Residential College | false |
| Status | 即將出版Forthcoming |
| Hyaluronic Acid-based Supramolecular Nanomedicine with Optimized Ratio of Oxaliplatin/Chlorin e6 for Combined Chemotherapy and O2-Economized Photodynamic Therapy | |
Ding YF1 ; Xu X1; Li J1; Wang Z1; Luo J2; Mo SP(莫昇萍)1; Li S1 ; Wang R1
| |
| 2023-03 | |
| Source Publication | Acta Biomaterialia
 |
| Document Type | Journal article |
| Collection | University of Macau |
| Corresponding Author | Li S; Wang R |
| Affiliation | 1.University of Macau 2.UltraSpec Lab, Victoria, V8P 2N1, BC, Canada |
| First Author Affilication | University of Macau |
| Corresponding Author Affilication | University of Macau |
| Recommended Citation GB/T 7714 | Ding YF,Xu X,Li J,et al. Hyaluronic Acid-based Supramolecular Nanomedicine with Optimized Ratio of Oxaliplatin/Chlorin e6 for Combined Chemotherapy and O2-Economized Photodynamic Therapy[J]. Acta Biomaterialia, 2023. |
| APA | Ding YF., Xu X., Li J., Wang Z., Luo J., Mo SP., Li S., & Wang R (2023). Hyaluronic Acid-based Supramolecular Nanomedicine with Optimized Ratio of Oxaliplatin/Chlorin e6 for Combined Chemotherapy and O2-Economized Photodynamic Therapy. Acta Biomaterialia. |
| MLA | Ding YF,et al."Hyaluronic Acid-based Supramolecular Nanomedicine with Optimized Ratio of Oxaliplatin/Chlorin e6 for Combined Chemotherapy and O2-Economized Photodynamic Therapy".Acta Biomaterialia (2023). |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment